Translator Disclaimer
1 September 2018 PHARMACOKINETICS OF ORAL GABAPENTIN IN CARIBBEAN FLAMINGOS (PHOENICOPTERUS RUBER RUBER)
Author Affiliations +
Abstract

Gabapentin is a first-line treatment for neuropathic pain and adjunct anticonvulsant medication in humans and other species. Gabapentin may have advantages over other analgesics because of its broad therapeutic range with limited adverse effects and wide availability as an oral formulation. This study determined the pharmacokinetics of gabapentin in Caribbean flamingos (Phoenicopterus ruber ruber) after a single-dose oral administration of either 15 mg/kg (n = 6) or 25 mg/kg (n = 6). Plasma gabapentin concentrations were determined using liquid chromatography with mass spectrometry, and pharmacokinetic analysis was performed using noncompartmental methods. Respectively for the 15 mg/kg and 25 mg/kg dose, mean peak plasma concentration (Cmax) was (mean ± pseudo SD) 13.23 ± 1.47 and 24.48 ± 5.81 μg/ml; mean time to peak plasma concentration (Tmax) was 0.50 ± 0.24 and 0.56 ± 0.28 hr; mean area under the curve (AUC) was 76.0 ± 26.3 and 114.7 ± 27.5 hr·μg/ml; and mean terminal half-life (T1/2) was 3.39 ± 0.90 and 4.46 ± 1.12 hr. Based on the results of this study, gabapentin dosed at 25 mg/kg orally in most Caribbean flamingos is likely to maintain plasma concentrations above the therapeutic range established for humans for approximately 12 hr.

Copyright 2018 by American Association of Zoo Veterinarians
Geoffrey R. Browning, James W. Carpenter, Geraldine C. Magnin, and Butch KuKanich "PHARMACOKINETICS OF ORAL GABAPENTIN IN CARIBBEAN FLAMINGOS (PHOENICOPTERUS RUBER RUBER)," Journal of Zoo and Wildlife Medicine 49(3), (1 September 2018). https://doi.org/10.1638/2017-0245.1
Accepted: 30 April 2018; Published: 1 September 2018
JOURNAL ARTICLE
8 PAGES


SHARE
ARTICLE IMPACT
RIGHTS & PERMISSIONS
Get copyright permission
Back to Top